Elevate Continues Growth with Addition of Chief Scientific Officer

Kathleen Nelson, PhD Brings Specialized Expertise in Oncology and Immuno-Oncology

Elevate Healthcare today announced the appointment of Kathleen Nelson, PhD, as Chief Scientific Officer. Nelson brings more than 20 years of experience in medical education and scientific communications in a variety of settings including major universities, hospitals, and communication agencies. Kathleen holds a PhD in biochemistry from Temple University, and completed a postdoctoral fellowship in immunology at Fox Chase Cancer Center.

Prior to joining Elevate, Kathleen served as SVP, Scientific Officer at several of the industry’s top pharmaceutical and healthcare communications agencies, including Vox Medica and Dudnyk. Kathleen has also served as the editor of Fox Chase Cancer Center’s Scientific Report and was also an assistant professor in New York University’s biology department.

“Kathy’s deep expertise in oncology and immuno-oncology is well-aligned with our work in specialty markets, where she can add immediate impact to our clients,” said Lorna Weir, Founding Partner at Elevate Healthcare. “We are very much looking forward to Kathy’s scientific leadership, and her help in shaping the future of Elevate.”

Elevate Healthcare Marketing is taking one of the key principles of peer–to-peer commerce models—streamlined interface between individuals to accomplish mutual business goals—and applying it to agency process. Multiple layers of management hierarchy, time-consuming onboarding processes, and steep learning curves are replaced with increased transparency and accountability, and a higher degree of agility—digging in quicker, responding to a marketing or strategic challenge more thoroughly, and pivoting to provide potential solutions faster.

The latest industry leader to join the firm, Kathleen is helping to disrupt the status quo of the agency model—and changing the definition of what scientific direction in the agency world looks like.